Abstract
The recently concluded Angina With Extremely Serious Operative Mortality Evaluation
(AWESOME) was a randomized clinical trial of percutaneous coronary intervention versus
coronary bypass graft surgery among patients with medically refractory ischemia who
were at high risk for coronary bypass graft surgery because of ≥1 risk factors that
included severely reduced left ventricular (LV) function, defined as LV ejection fraction
<35%. This study reports the outcome of patients with LV ejection fraction <35% in
the randomized clinical trial and the physician-directed and patient choice registries
of the AWESOME study.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass.J Am Coll Cardiol. 2001; 38: 143-149
- A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The VA AWESOME multicenter registry.J Am Coll Cardiol. 2002; 39: 266-273
- Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia.J Am Coll Cardiol. 2003; 41: 1732-1738
- Coronary artery bypass grafting in severe left ventricular dysfunction.J Am Coll Cardiol. 1993; 22: 1411-1417
- Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.JAMA. 1994; 272: 1528-1534
- Influence of left ventricular function on survival after coronary artery bypass grafting.Ann Thorac Surg. 1997; 64: 437-444
- Coronary artery bypass grafting in patients with advanced left ventricular dysfunction.Ann Thorac Surg. 1998; 66: 1632-1639
- Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Implications for patient selection. The Multivessel Angioplasty Prognosis Study Group.Circulation. 1991; 83: 1905-1914
- Coronary angioplasty in patients with severe left ventricular dysfunction.J Am Coll Cardiol. 1990; 16: 807-811
- Late results of coronary angioplasty in patients with left ventricular ejection fractions ≤40%.Am J Cardiol. 1994; 73: 1047-1052
- Coronary Artery Surgery Study (CASS).Circulation. 1985; 72: V102-V109
- Coronary bypass surgery improves survival in high-risk unstable angina. Results of a Veterans Administration Cooperative study with an 8-year follow-up. Veterans Administration Unstable Angina Cooperative Study Group.Circulation. 1991; 84: III260-III267
- ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery.J Am Coll Cardiol. 1999; 34: 1262-1347
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf. Accessed March 16, 2002
- Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions ≤40%, 41% to 49%, and ≥50% having percutaneous coronary revascularization.Am J Cardiol. 2003; 91: 1168-1172
- Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.N Engl J Med. 2001; 344: 1879-1887
- Invasive compared with non-invasive treatment in unstable coronary artery disease.Lancet. 1999; 354: 708-715
- Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med. 2001; 345: 494-502
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention.Lancet. 2001; 358: 527-533
Article info
Publication history
Accepted:
March 15,
2004
Received in revised form:
March 15,
2004
Received:
November 26,
2003
Footnotes
☆This study was funded by the Cooperative Studies Program of the United States Department of Veterans Affairs Research and Development Service, Washington, DC.
Identification
Copyright
© 2004 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
